Categories: News

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DURHAM, N.C., Oct. 29, 2024 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2024 before the market opens on Tuesday, November 5, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.

To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.

A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company’s website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until November 4, 2025.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com  

Staff

Recent Posts

President Trump Signals Openness to Medical Cannabis-MMJ BioPharma Files Emergency Motion to DEA Administrator Terry Cole

MMJ BioPharma is taking its fight for FDA approved cannabis medicine directly to DEA Administrator…

1 hour ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Toronto, Ontario--(Newsfile Corp. - August 11, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM)…

3 hours ago

MyndTec Inc. Announces Planned Chief Financial Officer Transition

Mississauga, Ontario--(Newsfile Corp. - August 11, 2025) -  MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a…

4 hours ago

Chadwick S. Richard, M.D. Now Offering patients the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Chadwick S. Richard, M.D., an Internal medicine physician from Medical Clinic of Houston, gives patients the…

4 hours ago

tendercare Launches on Android, Helping Millions More Families Collaborate with Family Caregiving Tools

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- tendercare, the free, easy-to-use, and collaborative technology platform transforming…

4 hours ago

Garden Launches BLOOM to Make AI Drug Design IP-Aware in Real Time

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Garden today announced BLOOM (Branching Lookup Optimized for…

4 hours ago